Paulina Dabrowska-Schlepp

Title: Paulina Dabrowska-Schlepp: Innovator in Glycosylated Lysosomal Proteins

Introduction

Paulina Dabrowska-Schlepp is a prominent inventor based in Gundelfingen, Germany. She has made significant contributions to the field of biochemistry, particularly in the development of glycosylated lysosomal proteins. With a total of 2 patents, her work focuses on improving therapeutic efficacy for various diseases.

Latest Patents

Her latest patents include a groundbreaking invention related to glycosylated lysosomal proteins. This invention describes a lysosomal protein composition that comprises a variety of lysosomal proteins, which are potentially diversely glycosylated according to a specific glycosylation pattern. Notably, this pattern includes at least 45% paucimannosidic N-glycans. The method of production involves manufacturing the lysosomal protein composition in a bryophyte plant or cell. The medical and non-medical uses of this composition are significant, as it can include proteins like α-Galactosidase for treating Fabry Disease or β-Glucoceramidase for Gaucher's Disease. The unique glycosylation achieved through this method results in improved therapeutic efficacy, surprisingly even without the common mannose-6-phosphate found in CHO cell-produced lysosomal proteins.

Career Highlights

Paulina is currently associated with Eleva GmbH, where she continues her innovative work in biochemistry. Her research has the potential to revolutionize treatments for lysosomal storage disorders, making her a key figure in her field.

Collaborations

She collaborates with notable colleagues, including Andreas Busch and Fode Benjamin, who contribute to her research endeavors.

Conclusion

Paulina Dabrowska-Schlepp is a trailblazer in the field of glycosylated lysosomal proteins, with her inventions paving the way for enhanced therapeutic solutions. Her work exemplifies the impact of innovation in medical science.